Indication

Arteriosclerotic parkinsonism

Arteriosclerotic parkinsonism, historically referred to as vascular parkinsonism or arteriosclerotic pseudoparkinsonism, is a secondary parkinsonian syndrome of the central nervous system predominantly affecting older adults with underlying cerebrovascular disease. Read more about Arteriosclerotic parkinsonism

90 drugs 70 manufacturers

Advertisement

Drugs that treat it

Common Arteriosclerotic parkinsonism therapies.

Showing 64–72 of 90 drugs

Filter & compare in the drug finder →Opens the drug finder with Arteriosclerotic parkinsonism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Arteriosclerotic parkinsonism.

Arteriosclerotic parkinsonism, historically referred to as vascular parkinsonism or arteriosclerotic pseudoparkinsonism, is a secondary parkinsonian syndrome of the central nervous system predominantly affecting older adults with underlying cerebrovascular disease.

It is pathophysiologically characterized by ischemic injury—such as diffuse subcortical white matter ischemia and lacunar infarcts within the basal ganglia—that disrupts frontal-subcortical and striato-pallido-thalamocortical motor networks.

Clinically, it manifests as a symmetrical, lower-body parkinsonism characterized by early gait impairment, postural instability, and frequent falls, typically with an absence of resting tremor and poor responsiveness to dopaminergic therapy.

Associated neurological features frequently include pyramidal tract signs, pseudobulbar palsy, urinary dysfunction, and subcortical cognitive decline.

Personalize your experience

Follow Arteriosclerotic parkinsonism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it